ketamine has been researched along with Cephalgia Syndromes in 3 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ketamine was associated with short-term analgesia in many refractory headache patients with tolerable adverse events." | 1.48 | Ketamine for Refractory Headache: A Retrospective Analysis. ( Dayan, AC; Hernandez, MG; Lauritsen, CG; Rangavajjula, A; Schwenk, ES; Silberstein, SD; Torjman, MC; Viscusi, ER; Young, W, 2018) |
| "Ketamine has been suggested as a new treatment for this intractable population." | 1.46 | Ketamine Infusions for Treatment Refractory Headache. ( Marmura, MJ; Nahas, SJ; Pomeroy, JL; Viscusi, ER, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hoydonckx, Y | 1 |
| Singh, M | 1 |
| Gilron, I | 1 |
| Khan, J | 1 |
| Narouze, S | 1 |
| Dahan, A | 1 |
| Curtis, K | 1 |
| Cao, X | 1 |
| Kara, J | 1 |
| Bhatia, A | 1 |
| Schwenk, ES | 1 |
| Dayan, AC | 1 |
| Rangavajjula, A | 1 |
| Torjman, MC | 1 |
| Hernandez, MG | 1 |
| Lauritsen, CG | 1 |
| Silberstein, SD | 1 |
| Young, W | 1 |
| Viscusi, ER | 2 |
| Pomeroy, JL | 1 |
| Marmura, MJ | 1 |
| Nahas, SJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Ketamine for Refractory Chronic Migraine: a Pilot Study[NCT03896256] | Early Phase 1 | 6 participants (Actual) | Interventional | 2019-03-22 | Completed | ||
| A Multi-center Randomized Controlled Trial of Efficacy and Safety of Intravenous Ketamine for Chronic Daily Headaches: The KetHead Study[NCT05306899] | Phase 3 | 56 participants (Anticipated) | Interventional | 2022-06-01 | Recruiting | ||
| Cardiovascular and Neuropsychiatric Side Effects in Ketamine Analgesic Infusions in Acute Pain[NCT03979105] | 300 participants (Actual) | Observational | 2017-07-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for ketamine and Cephalgia Syndromes
| Article | Year |
|---|---|
Trial protocol for a multicenter randomized controlled trial to assess the efficacy and safety of intravenous ketamine for chronic daily headaches: the "KetHead" trial.
Topics: Adult; Headache; Headache Disorders; Humans; Ketamine; Multicenter Studies as Topic; N-Methylasparta | 2023 |
2 other studies available for ketamine and Cephalgia Syndromes
| Article | Year |
|---|---|
Ketamine for Refractory Headache: A Retrospective Analysis.
Topics: Adult; Aged; Analgesics; Female; Follow-Up Studies; Headache Disorders; Humans; Infusions, Intraveno | 2018 |
Ketamine for Refractory Headache: A Retrospective Analysis.
Topics: Adult; Aged; Analgesics; Female; Follow-Up Studies; Headache Disorders; Humans; Infusions, Intraveno | 2018 |
Ketamine for Refractory Headache: A Retrospective Analysis.
Topics: Adult; Aged; Analgesics; Female; Follow-Up Studies; Headache Disorders; Humans; Infusions, Intraveno | 2018 |
Ketamine for Refractory Headache: A Retrospective Analysis.
Topics: Adult; Aged; Analgesics; Female; Follow-Up Studies; Headache Disorders; Humans; Infusions, Intraveno | 2018 |
Ketamine Infusions for Treatment Refractory Headache.
Topics: Adolescent; Adult; Aged; Central Nervous System Agents; Comorbidity; Female; Headache Disorders; Hum | 2017 |
Ketamine Infusions for Treatment Refractory Headache.
Topics: Adolescent; Adult; Aged; Central Nervous System Agents; Comorbidity; Female; Headache Disorders; Hum | 2017 |
Ketamine Infusions for Treatment Refractory Headache.
Topics: Adolescent; Adult; Aged; Central Nervous System Agents; Comorbidity; Female; Headache Disorders; Hum | 2017 |
Ketamine Infusions for Treatment Refractory Headache.
Topics: Adolescent; Adult; Aged; Central Nervous System Agents; Comorbidity; Female; Headache Disorders; Hum | 2017 |
Ketamine Infusions for Treatment Refractory Headache.
Topics: Adolescent; Adult; Aged; Central Nervous System Agents; Comorbidity; Female; Headache Disorders; Hum | 2017 |
Ketamine Infusions for Treatment Refractory Headache.
Topics: Adolescent; Adult; Aged; Central Nervous System Agents; Comorbidity; Female; Headache Disorders; Hum | 2017 |
Ketamine Infusions for Treatment Refractory Headache.
Topics: Adolescent; Adult; Aged; Central Nervous System Agents; Comorbidity; Female; Headache Disorders; Hum | 2017 |
Ketamine Infusions for Treatment Refractory Headache.
Topics: Adolescent; Adult; Aged; Central Nervous System Agents; Comorbidity; Female; Headache Disorders; Hum | 2017 |
Ketamine Infusions for Treatment Refractory Headache.
Topics: Adolescent; Adult; Aged; Central Nervous System Agents; Comorbidity; Female; Headache Disorders; Hum | 2017 |